Merit Medical Systems, Inc. reported $1.58B of revenue over the trailing twelve months, +10% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.58B (to Q2 2026). Net income: $146M, trailing twelve months to Q2 2026. Free cash flow: $203M, trailing twelve months to Q2 2026. Operating margin: 13%, trailing twelve months to Q2 2026.

MMSIMerit Medical Systems, Inc.

Healthcare

$87.22+4.4% 1Y

$87.22

$60.3152 weeks$93.18

MMSI as reported

Merit Medical Systems, Inc. reported $1.58B of revenue over the trailing twelve months, +10% on the year before. 11 reported series are charted on this page, each one as filed.

$1.58B

Revenue, trailing twelve months · to Q2 2026 · +10% against the twelve months before

Net income: $146M
Net income · +22% year on year · trailing twelve months to Q2 2026
Free cash flow: $203M
Free cash flow · +5.7% year on year · trailing twelve months to Q2 2026
Operating margin: 13%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for MMSI, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.58B	+10%	Q2 2026
Net income	$146M	+22%	Q2 2026
EPS	$2.43	+23%	Q2 2026
Gross margin	49%	n/a	Q2 2026
Operating margin	13%	n/a	Q2 2026
Net margin	9.2%	n/a	Q2 2026
ROE	8.3%	n/a	Q2 2026
ROA	4.9%	n/a	Q2 2026
ROIC	7.7%	n/a	Q2 2026
Free cash flow	$203M	+5.7%	Q2 2026
P/E	35.9	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.